1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Mental Health Analysis & Statistics in East Asia, July 2019

Mental Health Analysis & Statistics in East Asia, July 2019

Customer Support

Talk to Veronica

+1 718 514 2762

All regions

data types

1-16 of 16 reports

South Korea Neurology Devices Market Outlook to 2025 - Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and Others

South Korea Neurology Devices Market Outlook to 2025 - Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and Others

  • $ 5995
  • Industry report
  • November 2018

South Korea Neurology Devices Market Outlook to 2025 - Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and OthersSummaryGlobalData’s new report, South Korea Neurology ...

  • Industries : Health Services, Healthcare, Patient Monitoring, Medical Device, Mental Health, Pathology
  • Countries : South Korea, East Asia
China Neurology Devices Market Outlook to 2025 - Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and Others

China Neurology Devices Market Outlook to 2025 - Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and Others

  • $ 5995
  • Industry report
  • November 2018

China Neurology Devices Market Outlook to 2025 - Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and OthersSummaryGlobalData’s new report, China Neurology Devices ...

  • Industries : Health Services, Healthcare, Patient Monitoring, Medical Device, Mental Health, Pathology
  • Countries : China, East Asia
Japan Neurology Devices Market Outlook to 2025 - Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and Others

Japan Neurology Devices Market Outlook to 2025 - Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and Others

  • $ 5995
  • Industry report
  • November 2018

Japan Neurology Devices Market Outlook to 2025 - Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and OthersSummaryGlobalData’s new report, Japan Neurology Devices ...

  • Industries : Health Services, Healthcare, Patient Monitoring, Medical Device, Mental Health, Pathology
  • Countries : Japan, East Asia
EPIOMIC EPIDEMIOLOGY SERIES: AUTISM SPECTRUM DISORDERS FORECAST IN 22 MAJOR MARKETS 2018–2028

EPIOMIC EPIDEMIOLOGY SERIES: AUTISM SPECTRUM DISORDERS FORECAST IN 22 MAJOR MARKETS 2018–2028

  • $ 5577
  • Industry report
  • April 2018

Black Swan Analysis Epiomic™ Epidemiology Forecast Report on Autism Spectrum Disorders in 22 Major MarketsAutism Spectrum Disorders (ASD) or Pervasive Developmental Disorder (PDD) defines a group of ...

  • Industries : Mental Health, Pathology
  • Countries : Western Europe, East Asia, South Korea
PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis to 2026

PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis to 2026

  • $ 10995
  • Industry report
  • October 2017

PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis to 2026SummaryEpilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. Seizures result from abnormal ...

  • Industries : Mental Health, Pathology
  • Countries : United States, Japan, North America, East Asia
Epilepsy Therapeutic Market in APAC 2017-2021

Epilepsy Therapeutic Market in APAC 2017-2021

  • $ 2500
  • Industry report
  • June 2017

About Epilepsy Therapeutic Epilepsy is a neurological condition that affects the nervous system. It is characterized by the occurrence of two or more unprovoked seizures. A seizure is defined as the disruption ...

  • Industries : Mental Health, Therapy, Pathology, Pharmaceutical
  • Countries : Japan, World, East Asia, China, Australia, India
Epiomic Epidemiology Series: Vascular Dementia Forecast in 13 Major Markets 2017-2027

Epiomic Epidemiology Series: Vascular Dementia Forecast in 13 Major Markets 2017-2027

  • $ 4087
  • Industry report
  • January 2017

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Vascular Dementia in 13 Major MarketsVascular Dementia (VaD) is the second most common form of dementia after Alzheimer disease. It ...

  • Industries : Mental Health, Pathology
  • Countries : East Asia
PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • November 2016

PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2025SummarySchizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disorde ...

  • Industries : Mental Health, Pathology
  • Countries : United States, Japan, North America, East Asia
PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

  • $ 10995
  • Industry report
  • October 2016

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025SummaryMajor depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. Similar to othe ...

  • Industries : Therapy, Pharmaceutical, Mental Health, Pathology
  • Countries : United States, Japan, North America, East Asia, World
Bipolar disorder, Datamonitor Healthcare

Bipolar disorder, Datamonitor Healthcare

  • $ 5000
  • Industry report
  • June 2016

Generic dominance will prevent the growth of the bipolar disorder market, and few pipeline candidates show promise to completely reverse this trend.This report addresses the following questions:- What ...

  • Industries : Mental Health, Pathology
  • Countries : United States, North America, Japan, European Union, East Asia, Europe
Schizophrenia

Schizophrenia

  • $ 5000
  • Industry report
  • April 2016

Schizophrenia’s unmet needs can be turned into key commercial opportunities to drive the growth of the market.This report addresses the following questions: - What will be the key growth drivers of the ...

  • Industries : Mental Health, Pathology
  • Countries : United States, Japan, European Union, North America, Europe, East Asia
Alzheimer's disease

Alzheimer's disease

  • $ 5000
  • Industry report
  • March 2016

Amyloid-targeting immunotherapies may create a $10bn opportunity within the Alzheimer’s disease market.This report addresses the following questions: - How will the approval of immunotherapies affect ...

  • Industries : Mental Health, Pathology
  • Countries : United States, Japan, European Union, East Asia, North America, Europe
Multiple sclerosis

Multiple sclerosis

  • $ 5000
  • Industry report
  • January 2016

Competition is mounting in the lucrative multiple sclerosis market, as new entrants and late-stage pipeline candidates look to capture market share from established players.This report addresses the following ...

  • Industries : Mental Health, Pathology
  • Countries : United States, European Union, North America, Europe, Japan, East Asia
Stroke

Stroke

  • $ 5000
  • Industry report
  • January 2016

Due to their extended dosing durations, patients receiving treatment for the secondary prevention of ischemic stroke are the most commercially relevant patient subgroup.This report addresses the following ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States, Japan, European Union, North America, East Asia, Europe
Parkinson's disease

Parkinson's disease

  • $ 5000
  • Industry report
  • April 2015

Population aging and the introduction of new therapies for late-stage disease will grow the mature Parkinson’s disease marketThis report addresses the following questions:- What will be the growth drivers ...

  • Industries : Mental Health, Pathology
  • Countries : United States, European Union, Japan, North America, Europe, East Asia
Asian Internal Neurostimulaiton/Neuromodulation Market, by Modality -Forecast to 2019

Asian Internal Neurostimulaiton/Neuromodulation Market, by Modality -Forecast to 2019

  • $ 2603
  • Industry report
  • March 2015

The Asia-Pacific internal neurostimulation/neuromodulation market is estimated to register a CAGR of 13.8% between 2014 and 2019. Although the mature market of Japan holds the largest share in the internal ...

  • Industries : Mental Health, Pathology
  • Countries : East Asia, World, APAC


Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on